As reported by IPWatchdog, Moderna is facing lawsuits in the United States from biotech firms, Arbutus Biopharma Corporation and Genevant Sciences GmbH.
Both companies allege that Moderna has infringed six of their U.S. patents relating to lipid nanoparticle (“LNP”) delivery technology. LNP delivery systems are crucial for mRNA therapies like Moderna’s COVID-19 vaccine by allowing treatments to bypass the human immune system without being destroyed.
Moderna has reportedly denied all allegations and vowed to vigorously defend itself against the claims made against it in court.
The plaintiffs in this action are seeking compensation, rather than an injunction, which is typically sought in such actions. If infringement is found, compensation through damages would likely be assessed through a “reasonable royalty”.
Veteran rock photographer, Neil Zlozower, reportedly sued the Rock & Roll Hall of Fame for allegedly using his copyrighted images of Eddie Van Halen in its museum exhibits without his permission…
The U.S. District Court for the Eastern District of Washington (“District Court”) reportedly reinstated the Canadian government’s patent for the “Staccato” cherry, developed by Agriculture and…
As reported by the Associated Press, Columbia Sportswear has sued Columbia University, claiming that the university infringed the sportswear company’s trademark and breached an agreement between the…
Verizon and Headwater Research LLC have reportedly agreed to settle a patent infringement lawsuit that ended with a $175 million USD jury verdict against the telecom giant. Headwater, a…
In a recent copyright infringement case, the Jiangsu High Court ruled in favor of Nintendo, awarding the company approximately $28,000 USD, or 200,000 RMB, and an injunction against an unnamed…
Recent tariff measures affecting pharmaceutical products and ingredients have introduced new compliance and cost considerations for manufacturers, distributors, and importers operating in Canada and…
